Therapeutic application of neprilysin-mediated amyloid-β peptide-degrading system in Alzheimer's disease

被引：0
|
作者：
Iwata, N
Saito, T
Huang, SM
Takaki, Y
Higuchi, M
Takano, J
Matthias, S
Saido, TC
机构：
[1] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Saitama 3510198, Japan
[2] Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2005年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：81P / 81P
页数：1
相关论文
共 50 条
  • [1] Aβ31-35 Decreases Neprilysin-Mediated Alzheimer's Amyloid-β Peptide Degradation
    Leite, Jose P.
    Lete, Marta G.
    Fowler, Susan B.
    Gimeno, Ana
    Rocha, Juliana F.
    Sousa, Sergio F.
    Webster, Carl, I
    Jimenez-Bar Bero, Jesus J.
    Gales, Luis
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (19): : 3708 - 3718
  • [2] The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain
    Watamura, Naoto
    Kakiya, Naomasa
    Fujioka, Ryo
    Kamano, Naoko
    Takahashi, Mika
    Nilsson, Per
    Saito, Takashi
    Iwata, Nobuhisa
    Fujisawa, Shigeyoshi
    Saido, Takaomi C.
    SCIENCE SIGNALING, 2024, 17 (848)
  • [3] The immune system, amyloid-β peptide, and Alzheimer's disease
    Weksler, ME
    Gouras, G
    Relkin, NR
    Szabo, P
    IMMUNOLOGICAL REVIEWS, 2005, 205 : 244 - 256
  • [4] Alzheimer's Disease and the Amyloid-β Peptide
    Murphy, M. Paul
    LeVine, Harry, III
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 311 - 323
  • [5] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Saido, TC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 51P - 51P
  • [6] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Higuchi, M
    Saido, TC
    PHARMACOLOGY & THERAPEUTICS, 2005, 108 (02) : 129 - 148
  • [7] Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders
    Saxena, Shailendra K.
    Ansari, Saniya
    Maurya, Vimal K.
    Kumar, Swatantra
    Sharma, Deepak
    Malhotra, Hardeep S.
    Tiwari, Sneham
    Srivastava, Chhitij
    Paweska, Janusz T.
    Abdel-Moneim, Ahmed S.
    Nityanand, Soniya
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024,
  • [8] Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
    Yoon, Sang-Sun
    Jo, Sangmee Ahn
    BIOMOLECULES & THERAPEUTICS, 2012, 20 (03) : 245 - 255
  • [9] The role of RAGE in amyloid-β peptide-mediated pathology in Alzheimer's disease
    Schmidt, Ann Marie
    Sahagan, Barbara
    Nelson, Robert B.
    Selmer, Johan
    Rothlein, Robert
    Bell, Joanne M.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (07) : 672 - 680
  • [10] Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease:: review and hypothesis
    Qiu, WQ
    Folstein, MF
    NEUROBIOLOGY OF AGING, 2006, 27 (02) : 190 - 198
12345